Stephen MacMahon AO's Publications

About Stephen MacMahon AO's Publications

Founding Director, The George Institute for Global Health
  • Professor of Cardiovascular Medicine, Faculty of Medicine, UNSW Sydney
  • Chair of Global Health, Faculty of Medicine, Imperial College of London

  • Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trial

    Cerebral Circulation - Cognition and Behavior Date published:

  • The Effects of a Perindopril-Based Regimen in Relation to Statin Use on the Outcomes of Patients with Vascular Disease: a Combined Analysis of the ADVANCE, EUROPA, and PROGRESS Trials

    Cardiovascular Drugs and Therapy Date published:

  • Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials

    The Lancet Date published:

  • Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

    The Lancet Diabetes & Endocrinology Date published:

  • Polypills for the prevention of cardiovascular disease: a framework for wider use

    Nature Medicine Date published:

  • Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress

    International Journal of Stroke Date published:

  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

    The Lancet Date published:

  • PROGRESS in Blood Pressure Control for the Prevention of Secondary Stroke

    Cerebrovascular Diseases Date published:

  • Cover Image, Volume 23, Issue 8

    Diabetes, Obesity and Metabolism Date published:

  • The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure-Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial

    Diabetes Care Date published:

  • Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trial

    Diabetes, Obesity and Metabolism Date published:

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

    The Lancet Date published:

  • Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis

    The Lancet Oncology Date published:

  • Author response for "Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trial"

    Unknown Date published:

  • The KDR (VEGFR-2) Genetic Polymorphism Q472H and c-KIT Polymorphism M541L Are Associated With More Aggressive Behaviour in Astrocytic Gliomas

    Cancer Genomics - Proteomics Date published:

  • Obesity as a risk factor for COVID -19 mortality in women and men in the UK biobank: Comparisons with influenza/pneumonia and coronary heart disease

    Diabetes, Obesity and Metabolism Date published: